Quantitative 19F imaging of nmol-level F-nucleotides/-sides from 5-FU with T2 mapping in mice at 9.4T

Magnetic Resonance in Medicine

Volumn 62, Issue 5, 2009, Pages 1129-1139

  Doi, Yoshihiro ^a   Shimmura, Toshiyuki ^a   Kuribayashi, Hideto ^a   Tanaka, Yoshitsugu ^a   Kanazawa, Yoko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

19F image; F nucleosides; F nucleotides; Mouse; T2

Indexed keywords

MAGNETIC SUSCEPTIBILITY; MAMMALS; MAPPING; MOLECULAR IMAGING; NUCLEOTIDES;

5-FLUOROURACIL (5-FU); ACQUISITION PARAMETERS; IMAGE INTENSITIES; LINEAR CORRELATION; MOUSE; MR SPECTROSCOPIC IMAGING; POTENTIAL CAPABILITY; ^19F IMAGE;

METABOLITES;

DRUG METABOLITE; FLOXURIDINE PHOSPHATE; FLUORINE; FLUOROURACIL; FLUOROURIDINE TRIPHOSPHATE;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG TISSUE LEVEL; FEMALE; FLUORINE NUCLEAR MAGNETIC RESONANCE; IN VIVO STUDY; ISOTOPE LABELING; MOLECULAR IMAGING; MOUSE; NONHUMAN; PHARMACODYNAMICS; QUANTITATIVE ANALYSIS;

EID: 70449393276     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.22075     Document Type: Article

References (40)

1. 19F NMR. Br J Cancer 1984;50:113-117.
2. Wolf W, Albright MJ, Silver MS, Weber H, Reichardt U, Sauer R. Fluorine-19 NMR spectroscopic studies of the metabolism of 5-fluorouracil in the liver of patients undergoing chemotherapy. Magn Reson Imaging 1987;5:165-169. (Pubitemid 17133352)
3. 19F MRS studies of fluoropyrimidine chemotherapy. A review. NMR Biomed 1989;2:133-141.
4. 19F NMR spectroscopic pharmacokinetics in tumor-bearing humans and rabbits. Proc Natl Acad Sci U S A 1990;87:492-496.
5. Semmler W, Bachert-Baumann P, Gückel F, Ermark F, Schlag P, Lorenz WJ, van Kaick G. Real-time follow-up of 5-fluorouracil metabolism in the liver of tumor patients by means of F-19 MR spectroscopy. Radiology 1990;174:141-145. (Pubitemid 20017098)
6. Stegman LD, Rehemtulla A, Beattie B, Kievit E, Lawrence TS, Blasberg RG, Tjuvajev JG, Ross BD. Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy. Proc Natl Acad Sci U S A 1999;96:9821-9826. (Pubitemid 29398816)
7. 19F-MRS studies of fluorinated drugs in humans. Adv Drug Deliv Rev 2000;41:55-74.
8. Hartmann K-U, Heidelberger C. Studies on fluorinated pyrimidines XIII. Inhibition of thymidylate synthetase. J Biol Chem 1961;236:3006-3013.
9. McSheehy PMJ, Prior MJW, Griffiths JR. Prediction of 5-fluorouracil cytotoxicity towards the Walker carcinosarcoma using peak integrals of fluoronucleotides measured by MRS in vivo. Br J Cancer 1989;60:303-309.
10. Sijens PE, Baldwin NJ, Ng TC. Multinuclear MR investigation of the metabolic response of the murine RIF-1 tumor to 5-fluorouracil chemotherapy. Magn Reson Med 1991;19:373-385.
11. 19F magnetic resonance spectroscopy. Magn Reson Imaging 1992;10:385-392.
12. McSheehy PMJ, Robinson SP, Ojugo ASE, Aboagye EO, Cannell MB, Leach MO, Judson IR, Griffiths JR. Carbogen breathing increases 5-fluorouracil uptake and cytotoxicity in hypoxic murine RIF-1 tumors: a magnetic resonance study in vivo. Cancer Res 1998;58:1185-1194.
13. Kamm YJ, Peters GJ, Hull WE, Punt CJ, Heerschap A. Correlation between 5-fluorouracil metabolism and treatment response in two variants of C26 murine colon carcinoma. Br J Cancer 2003;89:754-762. (Pubitemid 37076185)
14. 19F-NMR spectroscopy of tissues ex vivo with therapy response and toxicity for locoregional vs systemic infusion protocols. NMR Biomed 2004;17:101-131.
15. Hamstra DA, Lee KC, Tychewicz JM, Schepkin VD, Moffat BA, Chen M, Dornfeld KJ, Lawrence TS, Chenevert TL, Ross BD, Gelovani JT, Rehemtulla A. The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies. Mol Ther 2004;10:916-928. (Pubitemid 39429317)
16. 19F-magnetic resonance spectroscopy. J Clin Oncol 2000;18:255-261.
17. 19F MR imaging. Magn Reson Med 1995;34:302-307.
18. 19F MR imaging. Magn Reson Med 1999;42:936-943.
19. 19F NMR in vivo spectroscopy reflects the effectiveness of perfusion-enhancing vascular modifiers for improving gemcitabine chemotherapy. Magn Reson Med 2008;59:19-27.
20. 19F NMR of 2-deoxy-2-fluoro-D-glucose for tumor diagnosis in mice. An NDP-bound hexose analog as a new NMR target for imaging. NMR Biomed 1997;10:35-41.
21. Doi Y, Kanazawa Y. 19F chemical shift imaging of F-nuc formed from 5-FU in mouse tumor by fast spin echo. In: Blümler P, Blümich B, Botto R, Fukushima E, editors. Spatially resolved magnetic resonance. Weinheim: WILEY-VCH; 1998. p 413-419.
22. 19F chemical shift imaging in studies of mice with orally administered 5-fluorouracil. Magn Reson Med 2001;46:864-869.
23. 19F magnetic resonance spectroscopy. Clin Cancer Res 1996;2:339-345.
24. 19F magnetic resonance spectroscopy for the detection of fluorinated drugs in the human liver. Magn Reson Med 2003;50:303-308.
25. 1 relaxation time measurements using the variable nutation angle method. Magn Reson Med 2004;52:169-173.
26. Gonen O, Murphy-Boesch J, Li C-W, Padavic-Shaller K, Negendank WG, Brown TR. Simultaneous 3D NMR spectroscopy of proton-decoupled fluorine and phosphorus in human liver during 5-fluorouracil chemotherapy. Magn Reson Med 1997;37:164-169. (Pubitemid 27045386)
27. Lin C-C, Hsu C-H, Huang C-Y, Cheng A-L, Chen J, Vogelzang NJ, Pu Y-S. Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: an effective regimen with low toxicity. Cancer 2006;106:1269-1275. (Pubitemid 43363903)
28. Kanazawa Y, Yamane H, Shinohara S, Kuribayashi S, Momozono Y, Yamato Y, Kojima M, Masuda K. 2-Deoxy-2-fluoro-D-glucose as a functional probe for NMR: the unique metabolism beyond its 6-phosphate. J Neurochem 1996;66:2113-2120. (Pubitemid 26118805)
29. Kanazawa Y, Momozono Y, Ishikawa M, Yamada T, Yamane H, Haradahira T, Maeda M, Kojima M. Metabolic pathway of 2-deoxy-2-fluoro-D-glucose studied by F-19 NMR. Life Sci 1986;39:737-742. (Pubitemid 16011463)
30. 19F chemical shift selective fast spin echo for metabolic mapping - characteristic tumor diagnosis by fluorinated hexoses. In: Naruse S, Watari H, editors. Ultrafast magnetic resonance imaging in medicine. Amsterdam: Elsevier Science: 1999. p 267-270.
31. 19F-NMR resonances from the fluorouracil anabolites involved in fluoropyrimidine chemotherapy. NMR Biomed 1999;12:237-248.
32. Keniry M, Benz C, Shafer RH, James TL. Noninvasive spectroscopic analysis of fluoropyrimidine metabolism in cultured tumor cells. Cancer Res 1986;46:1754-1758. (Pubitemid 16121504)
33. 19F MRI: a comparative animal study. Nucl Med Biol 1996;23:897-906.
34. 19F NMR comparative study of 5-fluorouracil, 1-(2-tetrahydrofuryl)-5- fluorouracil (FT) and an FT-uracil coadministration system in mouse tumors. Chem Pharm Bull 1994;42:774-778.
35. Honda H, Kanako K, Kanazawa Y, Hayashi T, Fukuya T, Matsumata T, Maeda T, Masuda K. MR imaging of hepatocellular carcinomas: effect of Cu and Fe contents on signal intensity. Abdom Imaging 1997;22:60-66. (Pubitemid 27030218)
36. +-ATPase in mouse bladder epithelium is responsible for urinary acidification. FEBS Lett 1997;404:61-64.
37. Birder LA, Nakamura Y, Kiss S, Nealen ML, Barrick S, Kanai AJ, Wang E, Ruiz G, de Groat WC, Apodaca G, Watkins S, Caterina MJ. Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat Neurosci 2002;5:856-860. (Pubitemid 34976650)
38. 19fluorine magnetic resonance spectroscopy at 1.5 and 3 Tesla field strength. Cancer Res 2003;63:7609-7612.
39. van Laarhoven HWM, Klomp DWJ, Rijpkema M, Kamm YJL, Wagener DJTh, Barentsz JO, Punt CJA, Heerschap A. Prediction of chemotherapeutic response of colorectal liver metastases with dynamic gadolinium-DTPA-enhanced MRI and localized 19F MRS pharmacokinetic studies of 5-fluorouracil. NMR Biomed 2007;20:128-140. (Pubitemid 46470935)
40. 19F MR spectroscopy at 3 T to detect heterogenous capecitabine metabolism in human liver. NMR Biomed 2007;20:485-492.